Consistent with the characteristic metabolic shift observed in cancer cells, mitochondrial localization of FGFR1 and ErbB2 contributes to reduced OXPHOS in lung and breast cancer, respectively [19, 20]. Here, ERBB2 is linked to breast cancer.